Lindbrook Capital, LLC Mesoblast LTD Transaction History

Lindbrook Capital, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$1.22 - $4.83 $1,069 - $4,235	-877 Reduced 52.93%	780 $0
Q2 2023 Jul 28, 2023	SELL	$2.95 - $4.44 $2,368 - $3,565	-803 Reduced 32.64%	1,657 $6,000
Q1 2023 Apr 26, 2023	BUY	$2.94 - $4.18 $3,257 - $4,631	1,108 Added 81.95%	2,460 $8,000
Q4 2022 Jan 24, 2023	BUY	$2.73 - $3.7 $1,717 - $2,327	629 Added 87.0%	1,352 $0
Q3 2022 Nov 10, 2022	BUY	$0.48 - $3.48 $196 - $1,423	409 Added 130.25%	723 $2,000
Q2 2022 Aug 01, 2022	SELL	$2.22 - $4.54 $3,214 - $6,573	-1,448 Reduced 82.18%	314 $1,000
Q1 2022 Apr 21, 2022	SELL	$3.58 - $4.98 $1,156 - $1,608	-323 Reduced 15.49%	1,762 $7,000
Q4 2021 Jan 18, 2022	BUY	$4.17 - $7.09 $708 - $1,205	170 Added 8.88%	2,085 $10,000
Q3 2021 Nov 05, 2021	BUY	$5.87 - $7.85 $2,794 - $3,736	476 Added 33.08%	1,915 $12,000
Q3 2020 Nov 03, 2020	SELL	$11.33 - $19.81 $1,042 - $1,822	-92 Reduced 6.01%	1,439 $27,000
Q2 2020 Jul 27, 2020	BUY	$4.2 - $15.45 $953 - $3,507	227 Added 17.41%	1,531 $17,000
Q1 2020 Apr 22, 2020	BUY	$3.38 - $10.63 $4,407 - $13,861	1,304 New	1,304 $6,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $1.2B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.